Papillary thyroid cancer laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Papillary thyroid cancer}}
{{Papillary thyroid cancer}}
{{CMG}}; {{AE}} {{Ammu}}
{{CMG}}; {{AE}} {{Ammu}} {{Sahar}}
==Overview==
==Overview==
Laboratory findings consistent with the diagnosis of papillary thyroid cancer include presence of tumor markers such as thyroglobulin. [[Thyroglobulin]] can be used as a [[tumor marker]] for well-[[Cellular differentiation|differentiated]] papillary thyroid cancer.
Laboratory findings consistent with the [[diagnosis]] of papillary thyroid cancer include presence of tumor markers such as [[thyroglobulin]]. [[Thyroglobulin]] can be used as a [[tumor marker]] for well-[[Cellular differentiation|differentiated]] papillary thyroid cancer.
==Laboratory Findings==
==Laboratory Findings==
* Laboratory findings consistent with the diagnosis of papillary thyroid cancer include presence of tumor markers such as thyroglobulin. [[Thyroglobulin]] can be used as a [[tumor marker]] for well-[[Cellular differentiation|differentiated]] papillary thyroid cancer.<ref name="pmid18060877">{{cite journal |author=Lin JD |title=Thyroglobulin and human thyroid cancer |journal=Clin Chim Acta |volume= 388|issue= 1–2|pages= 15–21|year=2007 |pmid=18060877 |doi=10.1016/j.cca.2007.11.002}}</ref><ref name="pmid17673127">{{cite journal |author=Tuttle RM, Leboeuf R, Martorella AJ |title=Papillary thyroid cancer: monitoring and therapy |journal=Endocrinol. Metab. Clin. North Am. |volume=36 |issue=3 |pages=753–78, vii |year=2007 |pmid=17673127 |doi=10.1016/j.ecl.2007.04.004}}</ref>  
* Laboratory findings consistent with the [[diagnosis]] of papillary thyroid cancer include presence of tumor markers such as [[thyroglobulin]]. [[Thyroglobulin]] can be used as a [[tumor marker]] for well-[[Cellular differentiation|differentiated]] papillary thyroid cancer.<ref name="pmid18060877">{{cite journal |author=Lin JD |title=Thyroglobulin and human thyroid cancer |journal=Clin Chim Acta |volume= 388|issue= 1–2|pages= 15–21|year=2007 |pmid=18060877 |doi=10.1016/j.cca.2007.11.002}}</ref><ref name="pmid17673127">{{cite journal |author=Tuttle RM, Leboeuf R, Martorella AJ |title=Papillary thyroid cancer: monitoring and therapy |journal=Endocrinol. Metab. Clin. North Am. |volume=36 |issue=3 |pages=753–78, vii |year=2007 |pmid=17673127 |doi=10.1016/j.ecl.2007.04.004}}</ref>  
* Reduced expression of [[ATP5E]] is significantly associated with the diagnosis of papillary thyroid cancer and may serve as an early tumor marker of the disease.<ref>{{cite journal|last1=Hurtado-López|first1=LM|last2=Fernández-Ramírez|first2=F|last3=Martínez-Peñafiel|first3=E|last4=Carrillo Ruiz|first4=JD|last5=Herrera González|first5=NE|title=Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?|journal=Medical science monitor : international medical journal of experimental and clinical research|date=16 June 2015|volume=21|pages=1745-51|pmid=26079849}}</ref>
* Reduced expression of [[ATP5E]] is significantly associated with the diagnosis of papillary thyroid cancer and may serve as an early tumor marker of the disease.<ref>{{cite journal|last1=Hurtado-López|first1=LM|last2=Fernández-Ramírez|first2=F|last3=Martínez-Peñafiel|first3=E|last4=Carrillo Ruiz|first4=JD|last5=Herrera González|first5=NE|title=Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?|journal=Medical science monitor : international medical journal of experimental and clinical research|date=16 June 2015|volume=21|pages=1745-51|pmid=26079849}}</ref>
* [[Thyroid cancer]] rarely affects thyroid endocrine function. Therefore, [[thyroid function test]] is not [[diagnostic]] for the papillary thyroid cancer.<ref>{{cite book | last = DeLellis | first = Ronald | title = Pathology and genetics of tumours of endocrine organs | publisher = IARC Press | location = Lyon | year = 2004 | isbn = 92-832-2416-7 }}</ref>
* [[Thyroid cancer]] rarely affects thyroid endocrine function. Therefore, [[thyroid function test]] is not [[diagnostic]] for the papillary thyroid cancer.<ref>{{cite book | last = DeLellis | first = Ronald | title = Pathology and genetics of tumours of endocrine organs | publisher = IARC Press | location = Lyon | year = 2004 | isbn = 92-832-2416-7 }}</ref>

Revision as of 19:16, 13 August 2019

Papillary thyroid cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Papillary thyroid cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Papillary thyroid cancer laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Papillary thyroid cancer laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Papillary thyroid cancer laboratory findings

CDC on Papillary thyroid cancer laboratory findings

Papillary thyroid cancer laboratory findings in the news

Blogs on Papillary thyroid cancer laboratory findings

Directions to Hospitals Treating Papillary thyroid cancer

Risk calculators and risk factors for Papillary thyroid cancer laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2] Sahar Memar Montazerin, M.D.[3]

Overview

Laboratory findings consistent with the diagnosis of papillary thyroid cancer include presence of tumor markers such as thyroglobulin. Thyroglobulin can be used as a tumor marker for well-differentiated papillary thyroid cancer.

Laboratory Findings

References

  1. Lin JD (2007). "Thyroglobulin and human thyroid cancer". Clin Chim Acta. 388 (1–2): 15–21. doi:10.1016/j.cca.2007.11.002. PMID 18060877.
  2. Tuttle RM, Leboeuf R, Martorella AJ (2007). "Papillary thyroid cancer: monitoring and therapy". Endocrinol. Metab. Clin. North Am. 36 (3): 753–78, vii. doi:10.1016/j.ecl.2007.04.004. PMID 17673127.
  3. Hurtado-López, LM; Fernández-Ramírez, F; Martínez-Peñafiel, E; Carrillo Ruiz, JD; Herrera González, NE (16 June 2015). "Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?". Medical science monitor : international medical journal of experimental and clinical research. 21: 1745–51. PMID 26079849.
  4. DeLellis, Ronald (2004). Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press. ISBN 92-832-2416-7.